Interestingly, it has been reported that cumulative survival rate of gastric cancer patients with PDCD4 expression was significantly higher compared to the patients without PDCD4 expression [11], impling PDCD4 as a promising target for future anticancer therapies in gastric cancer. The gene discussed is PDCD4; the disease is gastric cancer.